Cannabis is proving to be effective to treat all kinds of health-related issues including using medical cannabis for neurological conditions. Some of these conditions include epilepsy, autism, Alzheimer’s disease, migraine disorders, stroke, multiple sclerosis, Parkinson’s disease, and many others.
Recreational use of cannabis is now legal in a few states in the U.S. as of just a few short years ago, but the medicinal use of cannabis is legal in many states across the country and has been for much longer than recreational use. Doctors are turning to medical cannabis on a more consistent basis this day in age to help more effectively treat their patients, as clinical trials are showing positive results across many different studies.
It’s interesting to note that cannabis has been used to treat neurological conditions for hundreds or possibly even thousands of years. There isn’t enough scientific data for every neurological condition as it relates to using medical cannabis as a treatment product, but some of the more popular conditions and their results from cannabis use are outlined below.
Multiple sclerosis is perhaps the most studied neurological condition with cannabis used for therapeutic purposes, and the results have been positive for patients for helping to reduce body pains and aches.
Epileptic patients have reported beneficial uses of cannabis in terms of seizure suppression, but it’s more through basic scientific research as opposed to large clinical trials. Medical cannabis in the form of CBD has even been used safely by children to help cope with their epilepsy, and some parents have reported positive results after administering treatment.
Using medical cannabis to deal with Parkinson’s disease is a bit more complicated as cannabis can produce side effects including psychosis, memory problems, and fatigue – not good ones for those who have Parkinson’s disease. Plus medical cannabis as a treatment solution for Parkinson’s disease hasn’t been medically proven to be effective.
Medical cannabis use for migraines and headaches does occur, however, although compelling, the research has been basic in nature and clinical trials haven’t convinced researchers that its use is overwhelmingly positive.
Short-term side effects for medical cannabis range from anxiety, panic, impaired attention span and memory, psychosis, and tachycardia. Longer-term effects have been less studied to date, but some patients report a dependence on cannabis, bronchitis, increased risk for accidents including vehicular ones, and mild withdrawal symptoms have also been documented. No evidence has shown an increased risk for cancer, permanent psychiatric/cognitive deficits, or the ability to overdose on cannabis.
Data from clinical trials will no doubt be more extensive as the drug benefits from fewer legal restrictions, and more money is invested by cannabis companies to research positive and safe use.
Certain neurologic disorders have seen positive therapeutic benefits of medical cannabis, but additional research is needed to see more tailored uses of cannabis to clarify its role within the medical therapeutics space. Federal government support for cannabis use would also help to accelerate research efforts and improve the quality of clinical studies as well.